Want to join the conversation?
Mitra Ramgopal of Sidoti & Company asks about $CMN's Endoscopy performance and any benefits from the Custom Ultrasonics recall. CEO Andrew Krakauer said out of the 33.1% organic growth, about 5% came from Custom Ultrasonics. $CMN's organic growth ex Custom Ultrasonics was at 28.1%.
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.